{"schema":"hottub-news/story/v1","story":"st_t7qzjginxvdrgypogqyq","title":"STAT+: Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/stat-pharmalittle-were-reading-about-glp-1s-becoming-lifestyle-drugs-a-t7qzjginxv","count":1,"items":[{"id":"n_t7qzjginxvdrgypogqyq","seq":442571,"kind":"article","title":"STAT+: Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more","url":"https://www.statnews.com/pharmalot/2026/09/28/glp1-lifestyle-drug-marketing-merck-daiichi-lung-cancer-setback","summary":"Once promoted as tools to address obesity as a medical issue, GLP-1 drugs are increasingly being marketed as a way to look and feel better","published":"2026-09-28T13:06:52Z","seen":"2026-09-28T13:53:49Z","lang":"en","country":"US","source":{"id":"kite-statnews-com-aa5345","name":"statnews.com","domain":"statnews.com","outlet":{"wikidata":"Q28452506","name":"Stat","type":"website","designations":["business","news website","website"]}},"via":"kite-statnews-com-aa5345","topics":["healthcare","usa","medicine","pharma","pharmalot","pharmalittle","stat+"],"authors":["Ed Silverman"],"entities":[{"id":"Q96472579","name":"Merck","type":"org"},{"id":"Q49107945","name":"Best Denki (Taiwan)","type":"org"}],"image":"https://www.statnews.com/wp-content/uploads/2015/11/PHARMALOT_LITTLE-copy-645x645.jpg","mentions":2,"story":"st_t7qzjginxvdrgypogqyq","category":"health","category_p":0.4099999964237213,"category2":"economy-business","sentiment":"neutral","tone":-0.09000000357627869,"political":0.10000000149011612}]}